Aquinox Announces Closing of $75.4 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
23 sept. 2016 13h15 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Sept. 23, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Prices Public Offering of Common Stock
20 sept. 2016 00h19 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Proposed Public Offering of Common Stock
19 sept. 2016 16h14 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Initiates Patient Dosing in LEADERSHIP 301 Phase 3 Clinical Trial of AQX-1125 in Interstitial Cystitis/Bladder Pain Syndrome
06 sept. 2016 09h15 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing...
Aquinox Pharmaceuticals Announces Second Quarter 2016 Financial Results
04 août 2016 16h15 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals to Announce Second Quarter 2016 Financial Results
01 août 2016 09h20 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox to Present at Canaccord Genuity 36th Annual Growth Conference
01 août 2016 09h15 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox to Present at Jefferies 2016 Healthcare Conference
01 juin 2016 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, June 01, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Announces Executive Appointments
25 mai 2016 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, May 25, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox to Present at 2016 Annual UBS Global Healthcare Conference
18 mai 2016 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, May 18, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...